🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.7290
-0.0400 (-5.20%)
Nov 20, 2026, 5:29 PM CET

IRLAB Therapeutics AB Revenue

IRLAB Therapeutics AB had revenue of 6.93M SEK in the quarter ending September 30, 2026, a decrease of -63.22%. This brings the company's total for the last twelve months to 67.42M, down -21.20% year-over-year. In the year 2025, IRLAB Therapeutics AB had annual revenue of 57.46M, down -39.28%. That makes IRLAB Therapeutics AB the 39,049th largest company in the world by revenue and 541st in Sweden.

Revenue (ttm)
67.42M
Revenue Growth
-21.20%
P/S Ratio
1.61
Revenue / Employee
2.17M
Employees
28
Market Cap
108.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202557.46M-37.17M-39.28%
Dec 31, 202494.63M88.95M1,566.57%
Dec 31, 20235.68M-55.46M-90.71%
Dec 31, 202261.14M-146.65M-70.58%
Dec 31, 2021207.78M--
Dec 31, 20200--
Dec 31, 201926.00K8.00K44.44%
Dec 31, 201818.00K-91.00K-83.49%
Dec 31, 2017109.00K-35.00K-24.31%
Dec 31, 2016144.00K--
Dec 31, 20150--
Dec 31, 201454.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.